Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas

NEO-201 is a novel humanized IgG1 monoclonal antibody that was derived from an immunogenic preparation of tumor-associated antigens from pooled allogeneic colon tumor tissue extracts. It was found to react against a variety of cultured human carcinoma cell lines and was highly reactive against the m...

Descripción completa

Detalles Bibliográficos
Autores principales: Fantini, Massimo, David, Justin M., Saric, Olga, Dubeykovskiy, Alexander, Cui, Yongzhi, Mavroukakis, Sharon A., Bristol, Andrew, Annunziata, Christina M., Tsang, Kwong Y., Arlen, Philip M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758533/
https://www.ncbi.nlm.nih.gov/pubmed/29354121
http://dx.doi.org/10.3389/fimmu.2017.01899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758533/
https://www.ncbi.nlm.nih.gov/pubmed/29354121
http://dx.doi.org/10.3389/fimmu.2017.01899

Ejemplares similares